GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:GENT - NO0010748866 - Common Stock
53 NOK
-0.8 (-1.49%)
We assign a fundamental rating of 6 out of 10 to GENT. GENT was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While GENT has a great health rating, its profitability is only average at the moment. GENT is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year GENT was profitable.
In the past year GENT had a positive cash flow from operations.
GENT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
GENT has a Return On Assets of 18.25%. This is amongst the best in the industry. GENT outperforms 95.24% of its industry peers.
GENT has a Return On Equity of 21.37%. This is amongst the best in the industry. GENT outperforms 88.89% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.59%, GENT is in the better half of the industry, outperforming 63.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROIC | 7.59% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GENT has a Profit Margin of 25.83%. This is amongst the best in the industry. GENT outperforms 96.83% of its industry peers.
GENT's Operating Margin of 12.10% is in line compared to the rest of the industry. GENT outperforms 55.56% of its industry peers.
GENT's Gross Margin of 54.19% is in line compared to the rest of the industry. GENT outperforms 46.03% of its industry peers.
GENT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GENT is destroying value.
GENT has about the same amout of shares outstanding than it did 1 year ago.
GENT has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for GENT has been reduced compared to a year ago.
2.2 Solvency
GENT has an Altman-Z score of 15.71. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of GENT (15.71) is better than 96.83% of its industry peers.
The Debt to FCF ratio of GENT is 0.33, which is an excellent value as it means it would take GENT, only 0.33 years of fcf income to pay off all of its debts.
GENT has a Debt to FCF ratio of 0.33. This is amongst the best in the industry. GENT outperforms 95.24% of its industry peers.
GENT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of GENT (0.02) is better than 92.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Altman-Z | 15.71 |
ROIC/WACC0.89
WACC8.5%
2.3 Liquidity
GENT has a Current Ratio of 5.47. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
GENT has a Current ratio of 5.47. This is amongst the best in the industry. GENT outperforms 96.83% of its industry peers.
A Quick Ratio of 3.78 indicates that GENT has no problem at all paying its short term obligations.
GENT has a better Quick ratio (3.78) than 93.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 |
3. Growth
3.1 Past
GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2103.43%, which is quite impressive.
Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 11.68% in the last year.
The Revenue has been growing by 25.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
3.2 Future
GENT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.29% yearly.
GENT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.72% yearly.
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.70, GENT is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of GENT indicates a somewhat cheap valuation: GENT is cheaper than 76.19% of the companies listed in the same industry.
GENT is valuated rather cheaply when we compare the Price/Earnings ratio to 25.65, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 19.53, which indicates a rather expensive current valuation of GENT.
Based on the Price/Forward Earnings ratio, GENT is valued a bit cheaper than 60.32% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of GENT to the average of the S&P500 Index (34.45), we can say GENT is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.7 | ||
| Fwd PE | 19.53 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GENT is on the same level as its industry peers.
GENT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 86.35 | ||
| EV/EBITDA | 26.13 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GENT's earnings are expected to grow with 62.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
GENT has a yearly dividend return of 0.74%, which is pretty low.
Compared to an average industry Dividend Yield of 2.22, GENT has a dividend in line with its industry peers.
With a Dividend Yield of 0.74, GENT pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.74% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
OSL:GENT (11/25/2025, 12:07:48 PM)
53
-0.8 (-1.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.83%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap817.26M
Revenue(TTM)163.38M
Net Income(TTM)42.19M
Analysts85.71
Price Target68.34 (28.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.74% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.7 | ||
| Fwd PE | 19.53 | ||
| P/S | 5 | ||
| P/FCF | 86.35 | ||
| P/OCF | 41.08 | ||
| P/B | 4.14 | ||
| P/tB | 4.93 | ||
| EV/EBITDA | 26.13 |
EPS(TTM)2.69
EY5.08%
EPS(NY)2.71
Fwd EY5.12%
FCF(TTM)0.61
FCFY1.16%
OCF(TTM)1.29
OCFY2.43%
SpS10.6
BVpS12.81
TBVpS10.76
PEG (NY)0.33
PEG (5Y)N/A
Graham Number27.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROCE | 9.86% | ||
| ROIC | 7.59% | ||
| ROICexc | 12.65% | ||
| ROICexgc | 17.14% | ||
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% | ||
| FCFM | 5.79% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 115.57% | ||
| Cap/Sales | 6.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.08% | ||
| Profit Quality | 22.43% | ||
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | 15.71 |
F-Score5
WACC8.5%
ROIC/WACC0.89
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y257.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8223.43%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
What is the valuation status of GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?
ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for GENT stock?
The Price/Earnings (PE) ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 19.7 and the Price/Book (PB) ratio is 4.14.